Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Adv Chronic Kidney Dis. 2017 Sep;24(5):280–288. doi: 10.1053/j.ackd.2017.08.003

Table 1.

Cohort studies of participants with non-dialysis chronic kidney disease and their acid-base status

Cohort Time
period,
study
design,
country of
origin
n Study
population
Determination of
GFR
Acid-base measurement Summary of findings
on acid-base status
NephroTest8 1/2000–12/2006; prospective hospital-based; France 1,038 CKD stage 2–5
  • -

    mean age was 59 years

  • -

    31% were women

  • -

    6% were black

mGFR: measured by 51Cr-EDTA renal clearance; eGFR: estimated using 2 equations from the Modification
  • -

    mean mGFR was 37±17 ml/min per 1.73m2

Venous total CO2 measured using electrode
  • -

    acidosis defined as bicarbonate <22mEq/L or on bicarbonate therapy

  • -

    Overall prevalence of acidosis was 15%.

  • -

    22% of participants with acidosis were on bicarbonate therapy.

  • -

    The mGFR threshold for detecting acidosis with 90% sensitivity was 40 ml/min per 1.73m2.

Chronic Renal Insufficiency Cohort11,12,23 6/2003–12/2008 (enrollment); multicenter,observation al study; USA 3,939 eGFR 20–70 ml/min per 1.73m2
  • -

    mean age was 58 years

  • -

    45.2% were women

  • -

    41.8% were African American

  • -

    48.5% had diabetes

GFR was assessed by a CRIC internal GFR estimating equation validated against iothalamate 125 clearance testing that uses serum Cr, cystatin C, age, sex and race
  • -

    mean eGFR was 43±14 ml/min per 1.73m2

Serum bicarbonate measured using an enzymatic procedure with phosphoenolypyruvate carboxylase on the Ortho Vitros platform at the University of Pennsylvania Core Laboratory
  • -

    low bicarbonate defined as bicarbonate <22mEq/L

  • -

    Median serum bicarbonate level was 24 (IQR 22–26) mEq/L.

  • -

    Overall prevalence of low bicarbonate was 17.3%: 7% for CKD stage 2, 13% for stage 3 and 37% for stage 4.

African American Study of Kidney Disease and Hypertension13,14,28 2/1995–9/2001; multicenter, 3×2 factorial, randomized, controlled trial of intensive vs. standard blood pressure control; USA 1,094 GFR 20–65 ml/min per 1.73m2
  • -

    mean age was 54 years

  • -

    ~40% were women

GFR was assessed by renal clearance of iodine I125 iothalamate clearance
  • -

    mean GFR was 46 ml/min per 1.73m2

Serum bicarbonate was measured using either the kinetic ultraviolet method or a CO2 electrode
  • -

    Mean serum bicarbonate was 25.1 mEq/L

  • -

    4.3% had bicarbonate <20 mEq/L, 35.5% had bicarbonate between 20–24.9 mEq/L, and 5.5% had bicarbonate ≥30mEq/L

Health, Aging and Body Composition Study5 From 1997; prospective study of community elders; USA 2,287 Well-functioning adults aged 70–79 years
  • -

    mean age was 76 years

  • -

    51% were women

  • -

    38% were black

GFR was estimated using creatinine and cystatin C and CKD-EPI Collaboration creatinine-cystatin C equation49
  • -

    mean GFR was 82.1 ml/min per 1.73m2

Arterialized venous blood gas was obtained and measured at the point of care. Bicarbonate was calculated using the Henderson-Hasselbalch equation
  • -

    mean AVpH was 7.41

  • -

    mean bicarbonate was 25.1 mEq/L

  • -

    11% had bicarbonate <23 mEq/L and 10% had bicarbonate ≥28 mEq/L.

  • -

    association of bicarbonate and mortality was U-shaped with the lowest mortality at bicarbonate of 26mEq/L

National Health and Nutrition Examination Survey15 1999–2004; nationally representative survey, USA 9,781 Noninstitutionalized civilian
  • -

    mean age was 46 years

GFR was calculated using CKD-EPI Equation Bicarbonate was measured in 2 labs by the phosphoenolpyruvate carboxylase method from 1999–2001 and with a pH-sensitive electrode from 2002–2004; bicarbonate levels in 1999–2002 was adjusted by adding 1.105 mEq/L
  • -

    acidosis was defined as bicarbonate <23 mEq/L

  • -

    mean bicarbonate was 24.9 mEq/L

  • -

    Mean estimated NEAP was 57.4 mEq/d

  • -

    Greater dietary acid load is associated with lower bicarbonate.

Bronx, New York16 1/2001–12/2003 (baseline); retrospective cohort; USA 5,422 eGFR≥15 ml/min per 1.73m2
  • -

    mean age was 52 years

  • -

    69% were women

  • -

    25% were African American

  • -

    31% were Hispanic

  • -

    21% had diabetes

eGFR was calculated using the 4-variable Modification of Diet in Renal Disease Study equation
  • -

    9% with eGFR <60 ml/min per 1.73m2

Serum bicarbonate measured using an enzymatic procedure with phosphoenolypyruvate carboxylase at Montefiore Medical Center
  • -

    low bicarbonate was defined as ≤22mEq/L

  • -

    Prevalence of low bicarbonate was 20.7% for all, 20%, 21%, 48% for eGFR ≥60, 30–59 and 15–29 ml/min per 1.73m2, respectively

  • -

    mean bicarbonate was 23±4.3, 24.8±2.9 mEq/L for eGFR 15–29, ≥60 ml/min per 1.73m2, respectively

Chronic Kidney Disease in Children21,22 1/2005–8/2009*; observation al study; USA and Canada 586* eGFR 30–90 ml/min per 1.73m2
  • -

    median age was 11 years

  • -

    38% were female

  • -

    23% were black

  • -

    23% had glomerular disease

GFR was determined by directly measured plasma iohexol disappearance curve50
  • -

    median GFR was 44 ml/min per 1.73m2

Bicarbonate was measured locally using enzymatic method
  • -

    29% were on alkali therapy

  • -

    median bicarbonate was 22 mEq/L

  • -

    median bicarbonate was 24, 22, 21 mEq/L among those with GFR GFR≥50, ≥30 to <50, and <30 ml/min per 1.73m2, respectively

Abbreviation: USA, United States of America; GFR, glomerular filtration rate; mGFR, measured GFR; eGFR, estimated GFR; CRIC, Chronic Renal Insufficiency Cohort; Cr, creatinine; IQR, interquartile range; AVpH, arteriovenous pH; NEAP, net endogenous acid production, CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration

*

studied by Furth et al22